頁面路徑選單
- 首頁
- 市場技術報告
- 概觀
- 公司簡介/ 個案研究
- 0-9, A-E
- 報告資訊
Express Scripts, Inc. (ESRX) : Company Profile and SWOT Analysis
出版日期:2012/07/06
頁 數:36頁
文件格式:PDF
Synopsis
World Market Intelligence's 'Express Scripts, Inc. (ESRX) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, competitive benchmarking, key facts, key employees, location and subsidiaries as well as information on products and services.
Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
WMI's 'Express Scripts, Inc. (ESRX) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
WMI strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
• Examines and identifies key information and issues about 'Express Scripts, Inc.' for business intelligence requirements
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
• Provides analysis on financial ratios along with a competitor benchmarking section
• The profile also contains information on business operations, company history, major products and services, key employees
Reasons To Buy
• Quickly enhance your understanding of the company
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
• Recognize potential partnerships and suppliers
• Obtain yearly profitability figures
Key Highlights
Express Scripts Inc. (Express Scripts) is a provider of pharmacy benefit management (PBM) services in North America. The company distributes outpatient pharmaceuticals through a combination of benefit management services, including retail drug card programs, home delivery services, formulary management programs and other clinical management programs. It also distributes a wide range of injectible biopharmaceutical products directly to patients or their physicians, and provides cost-management and patient-care services. The company's clients include health maintenance organizations (HMOs), third-party administrators, union-sponsored benefit plans, health insurers, employers, workers' compensation plans and government health programs. Express Scripts is headquartered in St. Louis, Missouri, the US.
World Market Intelligence's 'Express Scripts, Inc. (ESRX) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, competitive benchmarking, key facts, key employees, location and subsidiaries as well as information on products and services.
Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
WMI's 'Express Scripts, Inc. (ESRX) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
WMI strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
• Examines and identifies key information and issues about 'Express Scripts, Inc.' for business intelligence requirements
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
• Provides analysis on financial ratios along with a competitor benchmarking section
• The profile also contains information on business operations, company history, major products and services, key employees
Reasons To Buy
• Quickly enhance your understanding of the company
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
• Recognize potential partnerships and suppliers
• Obtain yearly profitability figures
Key Highlights
Express Scripts Inc. (Express Scripts) is a provider of pharmacy benefit management (PBM) services in North America. The company distributes outpatient pharmaceuticals through a combination of benefit management services, including retail drug card programs, home delivery services, formulary management programs and other clinical management programs. It also distributes a wide range of injectible biopharmaceutical products directly to patients or their physicians, and provides cost-management and patient-care services. The company's clients include health maintenance organizations (HMOs), third-party administrators, union-sponsored benefit plans, health insurers, employers, workers' compensation plans and government health programs. Express Scripts is headquartered in St. Louis, Missouri, the US.
Table of Contents
1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset, Liabilities and Capex
2.2.3 Net Debt vs. Gearing Ratio
2.2.4 Solvency
2.2.5 Valuation
2.3 Competitive Benchmarking
2.3.1 Market Capitalization
2.3.2 Efficiency
2.3.3 Capital Expenditure
2.3.4 Valuation
2.3.5 Turnover – Inventory and Asset
2.3.6 Liquidity
3 SWOT Analysis
3.1 SWOT Analysis - Overview
3.2 Strengths
3.3 Weaknesses
3.4 Opportunities
3.5 Threats
4 Company Statement
5 History
6 Key Employees
7 Key Employee Biographies
8 Locations and Subsidiaries
8.1 Head Office
8.2 Other Locations and Subsidiaries
9 Appendix
9.1 Methodology
9.2 Ratio Definitions
9.3 Disclaimer
List of Tables
Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employees
Table 7: Key Employee Biographies
Table 8: Subsidiaries
List of Figures
Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Net Debt vs. Gearing Ratio
Figure 4: Solvency
Figure 5: Valuation
Figure 6: Market Capitalization
Figure 7: Efficiency
Figure 8: Capital Expenditure
Figure 9: Valuation
Figure 10: Turnover – Inventory and Asset
Figure 11: Liquidity
1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset, Liabilities and Capex
2.2.3 Net Debt vs. Gearing Ratio
2.2.4 Solvency
2.2.5 Valuation
2.3 Competitive Benchmarking
2.3.1 Market Capitalization
2.3.2 Efficiency
2.3.3 Capital Expenditure
2.3.4 Valuation
2.3.5 Turnover – Inventory and Asset
2.3.6 Liquidity
3 SWOT Analysis
3.1 SWOT Analysis - Overview
3.2 Strengths
3.3 Weaknesses
3.4 Opportunities
3.5 Threats
4 Company Statement
5 History
6 Key Employees
7 Key Employee Biographies
8 Locations and Subsidiaries
8.1 Head Office
8.2 Other Locations and Subsidiaries
9 Appendix
9.1 Methodology
9.2 Ratio Definitions
9.3 Disclaimer
List of Tables
Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employees
Table 7: Key Employee Biographies
Table 8: Subsidiaries
List of Figures
Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Net Debt vs. Gearing Ratio
Figure 4: Solvency
Figure 5: Valuation
Figure 6: Market Capitalization
Figure 7: Efficiency
Figure 8: Capital Expenditure
Figure 9: Valuation
Figure 10: Turnover – Inventory and Asset
Figure 11: Liquidity